NICE · NASDAQ · STOCK
NICE (NICE) Stock Analysis
$117.40
52W $83.10 – $138.58
60/100
$6.88B
16.8
0.04
⚠
Buy rating, but near-term risk/reward is unfavorable
The long-term recommendation is based on the composite investment score. The near-term risk/reward is based on nearby support and resistance levels. These can differ when a strong company trades close to resistance with support further below.
Is NICE Bullish or Bearish?
Bullish.
Innellis AI committee rates NICE Ltd. (NICE) Buy with a composite score of 60/100
, based on 6 analysts with 50% agreement.
Last updated October 10, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +15.50 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -4.50 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. News Analyst sees a compelling case — news sentiment is positive (+0.27 across 15 articles, 14d). Portfolio Manager remains cautious — sector concentration is already high (hhi 2796.97). This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- Low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock — Risk
- News sentiment is positive (+0.27 across 15 articles, 14d) — News
Bear Case
- EPS declining -17.6% YoY despite any revenue growth — Growth
- Bollinger bandwidth of 17.8% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 10, 2026
Overall Committee Score
60/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 44%
of 287 Technology peers
Value Analyst
bullish
62
/ 100 · Moderate confidence
Classic value case: cheap on multiples with earnings power to back it up
Growth Analyst
neutral
48
/ 100 · High confidence
Moderate growth -- present but not remarkable
+ Quarter-over-quarter growth rate is ACCELERATING, not just positive
− EPS declining -17.6% YoY despite any revenue growth
Technical Analyst
neutral
58
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
Risk Analyst
neutral
58
/ 100 · Moderate confidence
Moderate risk -- no single red flag, but nothing that clearly de-risks the position either
+ Low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock
− Bollinger bandwidth of 17.8% signals elevated volatility
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
bullish
66
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.27 across 15 articles, 14d)
Portfolio Manager
bearish
30
/ 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Investment Thesis Evolution
Committee score moved marginally from 59.5 to 59.5.
- New bearish signals: 1 appeared.
- Bearish pressure eased: 1 signal(s) disappeared.
Analyst-level changes:
- Risk Analyst: +1 bearish signal(s).
Comparing 2026-10-09 to 2026-10-10 (1 day apart).
Technical Analysis
RSI (14)
64.4
Neutral
MACD Histogram
0.289
Bullish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Hh Hl
Support
$99.16
Resistance
$118.25
Bollinger %B
0.76
Inside Bands
Price vs Moving Averages
EMA 9
$115.13
Above
EMA 21
$112.05
Above
EMA 50
$107.30
Above
EMA 200
$108.75
Above
Fundamental Analysis
Valuation
96
Growth
64
Profitability
87
Financial Health
72
Cash Flow
70
Valuation
P/E Ratio
16.8×
P/B Ratio
1.82×
PEG Ratio
-0.92
Dividend Yield
0.00%
52W High
$138.58
52W Low
$83.10
Quality & Growth
ROE
1579.0%
ROA
1198.8%
Gross Margin
6511.9%
Operating Margin
1851.9%
Revenue Growth YoY
—
Debt / Equity
0.02
AI Fundamental Assessment
P/E ratio of 16.8 (inexpensive relative to a 15-40x range); Price-to-book of 1.8x; PEG ratio of -0.9 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 15.8%; Return on assets of 12.0%; Net margin of 13.9%; Gross margin of 65.1%; Current ratio of 1.33 (tight short-term liquidity); Debt-to-equity of 0.02; Free cash flow per share is positive (10.64); Most recent quarter beat estimates by 0.1%; 2 consecutive earnings beats; EPS growth accelerating (-18.5% -> +2.3% QoQ); Analyst estimates falling over recent quarters
Get the Full NICE Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →